| Bioactivity | Alintegimod (7HP349) is a potent and orally active integrin activator. Alintegimod can serve as a systemically administered adjuvant to enhance T cell-mediated immune responses to vaccines[1]. |
| Name | Alintegimod |
| CAS | 1378535-08-0 |
| Formula | C28H32N2O6S4 |
| Molar Mass | 620.82 |
| Appearance | Liquid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Lokugamage N, et al. Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease. NPJ Vaccines. 2021 Sep 8;6(1):114. |
Alintegimod
CAS: 1378535-08-0 F: C28H32N2O6S4 W: 620.82
Alintegimod (7HP349) is a potent and orally active integrin activator. Alintegimod can serve as a systemically administe
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.